Evaluating CDK4/6 Inhibitor Safety Profiles: An Analysis of Adverse Events

A medical expert compares CDK4/6 inhibitors and discusses the importance of monitoring specific parameters, such as ECGs and laboratory tests, to minimize adverse events associated with each drug.